CHM chimeric therapeutics limited

valuation thoughts, page-145

  1. 49 Posts.
    lightbulb Created with Sketch. 86
    Speaking about Big Pharma's splurge into M&A and collaborations - this is the current list of collaborations from this weekend:

    (therapeutic area, upfront fee)
    1) Pfizer-Beam (base editing, $300m)
    2) Exact-PreventionGenetics (genetics testing, $190m M&A)
    3) Acadia-Stoke (rare disease, $60m)
    4) Moderna-Carisma (in vivo CAR-M, $45m)
    5) Bayer-Mammoth (gene editing, $40m)
    6) BMS-Century (IPSC iNK & T-Cell, 100m)

    I got this list from someone from twitter - crazy weekend.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.763M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.858K 619.3K

Buyers (Bids)

No. Vol. Price($)
66 58647032 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 107164382 32
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.